Subpart iv General Rating Process
Chapter 1 General Information on the Rating Activity
View All 1
Chapter 2 Reviewing Claims
View All 2
Chapter 3 Examinations
View All 6
Chapter 4 Rating Specific Disabilities
View All 15
Chapter 5 Evaluating Evidence and Making a Decision
View All 3
Chapter 6 The Rating Decision
View All 5
Chapter 7 Finalizing and Reviewing the Rating Decision
View All 2
Chapter 8 Competency, Due Process and Protected Ratings
View All 5
- M21-1, Part III, Subpart iv, Chapter 1 – General Information on the Rating Activity
- M21-1, Part III, Subpart iv, Chapter 2, Section A – Pre-Rating Review of Claims by the Rating Activity
- M21-1, Part III, Subpart iv, Chapter 3, Section A – Examination Requests Overview
- M21-1, Part III, Subpart iv, Chapter 4, Section A – Musculoskeletal Conditions
- M21-1, Part III, Subpart iv, Chapter 5, Section A – Principles of Reviewing Evidence and Decision Making
- M21-1, Part III, Subpart iv, Chapter 6, Section A – Partial Rating Decisions and Deferred Issues
- M21-1, Part III, Subpart iv, Chapter 7, Section A – Finalizing the Rating Decision
- M21-1, Part III, Subpart iv, Chapter 8, Section A – Evaluating Competency
- M21-1, Part III, Subpart iv, Chapter 3, Section B – Scheduling Examinations
- M21-1, Part III, Subpart iv, Chapter 3, Section C – Control of Examinations
- M21-1, Part III, Subpart iv, Chapter 3, Section D – Examination Reports
- M21-1, Part III, Subpart iv, Chapter 3, Section E – Department of Veterans Affairs (VA) Medical Facilities Liaison
- M21-1, Part III, Subpart iv, Chapter 3, Section F – Examinations in Special Situations
- M21-1, Part III, Subpart iv, Chapter 4, Section B – Musculoskeletal Diseases and Muscle Injuries
- M21-1, Part III, Subpart iv, Chapter 4, Section C – Conditions of the Eyes
- M21-1, Part III, Subpart iv, Chapter 4, Section D – Conditions of the Auditory System
- M21-1, Part III, Subpart iv, Chapter 4, Section E – Infectious Diseases, Immune Disorders, and Nutritional Deficiencies
- M21-1, Part III, Subpart iv, Chapter 4, Section F – Respiratory Conditions
- M21-1, Part III, Subpart iv, Chapter 4, Section G – Cardiovascular System Conditions
- M21-1, Part III, Subpart iv, Chapter 4, Section H – Digestive Conditions
- M21-1, Part III, Subpart iv, Chapter 4, Section I – Genitourinary Disabilities
- M21-1, Part III, Subpart iv, Chapter 4, Section J – Disabilities of the Gynecological System and Breast
- M21-1, Part III, Subpart iv, Chapter 4, Section K- Hematologic and Lymphatic Systems
- M21-1, Part III, Subpart iv, Chapter 4, Section L- Skin Conditions
- M21-1, Part III, Subpart iv, Chapter 4, Section M – Endocrine Conditions
- M21-1, Part III, Subpart iv, Chapter 4, Section N – Neurological Conditions and Convulsive Disorders
- M21-1, Part III, Subpart iv, Chapter 4, Section O – Mental Disorders
- M21-1, Part III, Subpart iv, Chapter 5, Section B – Principles of Disability Evaluation
- M21-1, Part III, Subpart iv, Chapter 5, Section C – Effective Dates
- M21-1, Part III, Subpart iv, Chapter 6, Section B – Determining the Issues
- M21-1, Part III, Subpart iv, Chapter 6, Section C – Completing the Rating Decision Narrative
- M21-1, Part III, Subpart iv, Chapter 6, Section D – Codesheet Section
- M21-1, Part III, Subpart iv, Chapter 6, Section E – Coded Conclusion
- M21-1, Part III, Subpart iv, Chapter 7, Section B – Reviewing the Rating Decision
- M21-1, Part III, Subpart iv, Chapter 8, Section B – Proposed Rating Decisions
- M21-1, Part III, Subpart iv, Chapter 8, Section C – Protected Ratings
- M21-1, Part III, Subpart iv, Chapter 8, Section D – Reductions in Awards
- M21-1, Part III, Subpart iv, Chapter 8, Section E – Other Due Process Concerns
- M21-1, Part III, Subpart iv, Chapter 2, Section B – Revision of Decisions